EV Based Platform for Monitoring Therapeutics Response During Pregnancy (ARISE)

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

July 2, 2024

Primary Completion Date

September 1, 2028

Study Completion Date

September 1, 2028

Conditions
Preeclampsia
Trial Locations (1)

43210

RECRUITING

The Ohio State University Wexner Medical Center OB/GYN Maternal and Fetal Medicine, Columbus

All Listed Sponsors
collaborator

University of Texas

OTHER

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

Ohio State University

OTHER